Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets
Ruisheng Yao(Washington University in St. Louis), Ming You(Houston Methodist), William J. Lemon, Yan Lü(Medical College of Wisconsin), David W. End(Johnson & Johnson (United States)), Ronald A. Lubet(National Cancer Institute), Yian Wang(Hunan Normal University), Clinton J. Grubbs(University of Alabama at Birmingham)
Cited by 11
Related Papers
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
|Nature Communications|2020|246
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
|Nature Communications|2019|242